Cheng Hu

Title: Innovations in Glaucoma Treatment by Cheng Hu

Introduction

Cheng Hu is a notable inventor based in Wenzhou, China, recognized for his contributions to medical technology, particularly in the field of glaucoma treatment. With a total of two patents to his name, he has developed innovative solutions aimed at improving patient outcomes and enhancing the quality of life for those suffering from glaucoma.

Latest Patents

Cheng Hu's latest patents include the "Inner drainage biomimetic stent for glaucoma and use thereof" and "Penetrating canaloplasty for treating angle-closure glaucoma." The inner drainage biomimetic stent is designed to facilitate the smooth flow of aqueous humor through an orifice expanded by the stent, effectively re-expanding a collapsed Schlemm's canal. This innovation aims to lower intraocular pressure, thereby addressing the challenges associated with glaucoma treatment. The penetrating canaloplasty method retains the advantages of traditional canaloplasty while avoiding complications related to blebs, which can negatively impact patients' quality of life. This non-filtering operation preserves the ocular surface's immunologic and physiologic structures, offering a promising alternative for angle-closure glaucoma patients.

Career Highlights

Cheng Hu has worked with reputable organizations such as Suzhou Purevision Medical Technology Co., Ltd. and Wenzhou Medical University. His experience in these institutions has allowed him to refine his skills and contribute significantly to the field of ophthalmology.

Collaborations

Cheng has collaborated with notable colleagues, including Yuanbo Liang and Xingyi Li, to advance his research and innovations in glaucoma treatment.

Conclusion

Cheng Hu's work exemplifies the intersection of innovation and healthcare, particularly in developing effective treatments for glaucoma. His patents reflect a commitment to improving patient care and advancing medical technology.